Skip to main content
. 2018 Oct 3;154(6):1385–1394. doi: 10.1016/j.chest.2018.09.006

Table 2.

Assessment of Diagnostic Validity of Each Clinical Tool

Diagnostic Tools Se % (95% CI) Sp % (95% CI) LR+ (95% CI) LR– (95% CI) PPV % (95% CI) NPV % (95% CI)
WHO pneumonia 66.3 (59.1-73.0) 52.7 (48.7-56.6) 1.40 (1.23-1.60) 0.64 (0.52-0.79) 29.4 (25.1-33.9) 84.0 (80.1-87.5)
Auscultation findings
 Presence of crackles 75.3 (68.5-81.2) 53.0 (49.0-56.9) 1.60 (1.43-1.80) 0.47 (0.36-0.60) 32.2 (27.9-36.8) 87.8 (84.1-90.9)
 Absence of wheezes 64.2 (57.0-71.0) 47.3 (43.4-51.3) 1.22 (1.07-1.39) 0.76 (0.61-0.93) 26.6 (22.6-30.9) 81.7 (77.4-85.5)
 Decreased breath sounds 23.2 (17.4-29.8) 91.6 (89.1-93.6) 2.74 (1.91-3.95) 0.84 (0.77-0.91) 44.9 (34.8-55.3) 80.1 (77.0-82.9)
Oxyhemoglobin saturation ≤ 95% 9.5 (5.7-14.6) 91.4 (89.0-93.5) 1.10 (0.66-1.83) 0.99 (0.94-1.04) 24.7 (15.3-36.1) 77.3 (74.1-80.2)
Oxyhemoglobin saturation ≤ 92% 40.0 (33.0-47.3) 71.6 (67.9-75.0) 1.41 (1.14-1.74) 0.84 (0.74-0.95) 29.5 (24.0-35.4) 80.1 (76.6-83.3)
Consolidation on lung ultrasound 55.3 (47.9-62.5) 95.0 (93.0-96.6) 11.05 (7.70-15.9) 0.47 (0.40-0.55) 76.6 (68.7-83.4) 87.7 (85.1-90.1)

LR+ = positive likelihood ratio, LR– = negative likelihood ratio; NPV = negative predictive value; PPV = positive predictive value; Se = sensitivity; Sp = specificity; WHO = World Health Organization.